Optiray (Ioversol)

Ioversol, the active ingredient in Optiray, is an iodinated contrast media presented as a sterile solution for intravenous use. It enhances the visibility of vascular structures and organs during diagnostic imaging procedures.

GNH USA supplies Optiray as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Optiray is an iodinated contrast agent used in radiographic procedures to improve image quality.

CT imaging: provides enhanced contrast for better visualization of anatomical structures. Angiography: improves delineation of blood vessels during vascular studies. Myelography: facilitates clear imaging of the spinal canal and surrounding tissues.

Adverse reactions may occur following administration of iodinated contrast agents.

Common Side Effects: - Warmth or flushing sensation at the injection site. - Nausea or mild vomiting. - Transient metallic taste in the mouth. - Mild headache or dizziness. - Injection site pain or bruising. - Mild urticaria or itching.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction. - Acute renal impairment, especially in patients with pre‑existing kidney disease. - Severe hypotension or cardiovascular collapse. - Pulmonary edema or respiratory distress. - Cardiac arrhythmias. - Seizures or neurologic disturbances.

Prior to using Optiray, clinicians should assess patient risk factors and follow safe handling practices.

Assess renal function: evaluate serum creatinine and eGFR before administration. Check iodine allergy history: obtain detailed patient allergy information. Ensure adequate hydration: encourage fluid intake before and after the procedure. Avoid in uncontrolled hyperthyroidism: consider risk of iodine load. Pregnancy: use only when essential and benefits outweigh risks. Store at ambient temperature: keep in original container, protect from light and moisture.

Ioversol may interact with certain medications, requiring caution.

Major Interactions (Avoid): - Nephrotoxic drugs: concurrent high‑dose aminoglycosides may exacerbate kidney injury. - Metformin: discontinue in patients with impaired renal function to prevent lactic acidosis. - Other iodine‑containing agents: avoid simultaneous use to reduce cumulative iodine load.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask contrast‑induced tachycardia. - Diuretics: monitor fluid balance and electrolytes. - ACE inhibitors or ARBs: watch for changes in renal function after contrast exposure.